4O91 | Crystal Structure of type II inhibitor NG25 bound to TAK1-TAB1 | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Gurbani, D., Hunter, J.C., Tan, L., Westover, K.D. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.39 | ||||||||||||
ligand | NG2 | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Discovery of Type II Inhibitors of TGFbeta-Activated Kinase 1 (TAK1) and Mitogen-Activated Protein Kinase Kinase Kinase Kinase 2 (MAP4K2)., Tan L, Nomanbhoy T, Gurbani D, Patricelli M, Hunter J, Geng J, Herhaus L, Zhang J, Pauls E, Ham Y, Choi HG, Xie T, Deng X, Buhrlage SJ, Sim T, Cohen P, Sapkota G, Westover KD, Gray NS, J Med Chem. 2014 Jul 30. PMID:25075558 |
Data retrieval |
View 4O91 in 3D |
Visual 3D analysis of 4O91 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4O91 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |